Delta Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Delta Investment Management's PFE Position: Q1 2026 in Review
Delta Investment Management reduced its Pfizer (PFE) stake by 1% in Q1 2026, selling an estimated $2.18K and leaving 8,019 shares worth $225K. The position accounts for 0.04% of the portfolio, ranked #242.
Delta Investment Management first reported a position in PFE in Q2 2019 and has held it in 28 quarters since. The position peaked at $674K in Q4 2022. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Delta Investment Management held 8,019 shares of Pfizer worth $225K as of Q1 2026.
- Delta Investment Management sold 82 Pfizer shares in Q1 2026, an estimated $2.18K.
- Pfizer made up 0.04% of Delta Investment Management's portfolio in Q1 2026, its #242 holding.
- Delta Investment Management first reported a position in Pfizer in Q2 2019 and has held it in 28 quarters since.
- Delta Investment Management's Pfizer position peaked at $674K in Q4 2022.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Delta Investment Management's 13F filing for Q1 2026, filed 13 May 2026.